Walmart to Begin Selling Biomerica’s Aware Breast Self Exam

Biomerica, Inc. (Nasdaq: BMRA) announced earlier today that its Aware® Breast Self Exam device will now be sold in Walmart’s retail system.

Shares of Biomerica, Inc. (Nasdaq: BMRA) gained over 26% during the premarket trading session following the announcement.

Zack Irani, Chief Executive Officer of Biomerica, commented, “Successful treatment of breast cancer is significantly enhanced by early detection.”

While Walmart will initially begin selling the product through its online sales channel in the USA, the Company is in negotiations with other partners for the distribution of the Aware® Breast Self Exam product in markets outside of the U.S.

“Our unique product provides a tool to assist women in potentially detecting breast abnormalities early. As one of the largest retail corporations in the world, Walmart provides unmatched visibility and distribution for this potentially life-saving product,” he continued.

The Aware® device can facilitate an effective self-exam and even serve as a reminder to perform a breast self-exam every month. In a study of 832 patients with breast cancer, fibroma, mastitis and non-tumorous conditions, the Aware® device was found to be “a highly effective instrument for the early detection of breast changes.”